From feature analysis we concluded that collagens, MACROH2A1, HPF1, COL4A3, TBB2C, actin, and H2B are promising targets for the understanding of tumor progression and development of distant metastases, and consequently inspiring novel treatment of PDAC metastatic lesions. This evidence concerns the gene MACROH2A1 and neoplasm.